Atlas FDA

BARTELS NEISSERIA GONORRHOEAE DIRECT FLUORESCENT

FDA 510(k) clearance K900546 · decided 1990-06-15

Clearance details

K-number
K900546
Device name
BARTELS NEISSERIA GONORRHOEAE DIRECT FLUORESCENT
Applicant
Baxter Healthcare Corp
Decision
Substantially Equivalent
Date received
1990-02-05
Decision date
1990-06-15
Days to decision
130 days
Clearance type
Traditional
Product code
GTH
Device class
2
Regulation number
866.3390
Medical specialty
Microbiology
Advisory committee
Microbiology
Location
Bellevue, WA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Baxter Healthcare Corp

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
MICROTRAK NEISERRIA GONORRHOEAE CULTURE TEST (K861835)Syva Co.1986-05-29
NEISSERIA GONORRHOEAE FLUORO-KIT (K800328)Clinical Sciences, Inc.1980-03-03

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
Floseal Hemostatic Matrix, Floseal with Recothrom; Floseal Hemostatic Matrix, Floseal Fast Prep; 3 Floseal Hemostatic Ma (P990009/S077)Baxter Healthcare Corp2025-11-13
FLOSEAL MATRIX/FLOSEAL MATRIX HEMOSTATIC SEALANT/PROCEED HEMOSTATIC SEALANT (P990009/S076)Baxter Healthcare Corp2025-06-30
Floseal Hemostatic Matrix (P990009/S075)Baxter Healthcare Corp2025-01-30
Adept Adhesion Reduction Solution (P050011/S009)Baxter Healthcare Corp2024-08-23
Floseal Hemostatic Matrix, Floseal with Recothrom, Floseal Hemostatic Matrix, Floseal Fast Prep (P990009/S074)Baxter Healthcare Corp2024-08-15
Floseal Hemostatic Matrix (P990009/S073)Baxter Healthcare Corp2024-01-10
Floseal Hemostatic Matrix, Fast Prep, Floseal Hemostatic Matrix, RTS (P990009/S072)Baxter Healthcare Corp2023-12-12
Floseal Hemostatic Matrix, RT5 (P990009/S070)Baxter Healthcare Corp2023-02-02